Paper Details 
Original Abstract of the Article :
OBJECTIVE: To compare efficacy and side effect profile data on conservative, behavioral, pharmacological, and surgical treatments used for pediatric saliva control. STUDY DESIGN: A cohort study of children (n = 483) referred to a specialty Saliva Control service between May 2014 and November 2019 w...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jpeds.2023.113803

データ提供:米国国立医学図書館(NLM)

Treatment Options for Pediatric Saliva Control

Drooling, or excessive saliva production, can be a real challenge for kids, especially when it impacts their social lives and self-esteem. This study, carried out by a team of experts, offers a comprehensive look at different treatment options for pediatric drooling. The study investigated the efficacy and side effects of a variety of interventions, including behavioral therapy, medication, and surgery, in a large cohort of children referred for saliva control. The researchers used standardized tools to assess the severity of drooling and the effectiveness of each treatment.

Botulinum Toxin and Duct Transpositional Surgery: Effective Solutions for Severe Drooling

The study revealed that intraglandular botulinum toxin A (BTX-A) injections and saliva duct transpositional surgery were the most effective treatments for severe drooling. BTX-A injections, which temporarily block nerve signals to the salivary glands, resulted in the greatest improvement in drooling. Duct transpositional surgery, which reroutes the salivary ducts to a different location, also demonstrated significant improvement in saliva control.

Oral Anticholinergics: A Good First-Line Option for Mild Drooling

For milder cases of drooling, oral anticholinergics, such as glycopyrronium bromide and trihexyphenidyl, were found to be effective and well-tolerated. These medications reduce saliva production by blocking the action of acetylcholine, a neurotransmitter that stimulates salivary glands. Inhaled ipratropium bromide, another anticholinergic medication, was found to be less effective than oral anticholinergics.

Dr.Camel's Conclusion

This research offers a valuable resource for parents and healthcare professionals struggling with pediatric drooling. The study helps us understand the nuances of different treatment options and their effectiveness. Like an oasis in the desert of drooling, this research provides a roadmap to help families find the best treatment for their child's specific situation.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-11-19
Further Info :

Pubmed ID

37898423

DOI: Digital Object Identifier

10.1016/j.jpeds.2023.113803

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.